Welcome to our dedicated page for Genpact SEC filings (Ticker: G), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Genpact Limited (NYSE: G) SEC filings, including current reports, registration statements, and other disclosures filed with the U.S. Securities and Exchange Commission. Genpact describes itself as an agentic and advanced technology solutions company, and its filings offer detailed insight into how it applies process intelligence and artificial intelligence within its business, as well as how it structures its capital and governance.
Investors can review Form 8-K filings for information on material events such as quarterly financial results, leadership changes, board appointments, and financing transactions. For example, recent 8-Ks discuss third quarter 2025 financial results, appointments of directors and senior officers, and the completion of a public offering of 4.950% Senior Notes due 2030 by Genpact UK Finco plc and Genpact USA, Inc., guaranteed by Genpact and Genpact Luxembourg.
Genpact also uses shelf registration statements and prospectus supplements on Form S-3 to register securities offerings, as reflected in the documentation supporting its 2030 senior notes. Credit agreement guarantees and supplemental indentures are described in exhibits to these filings, outlining covenants, guarantees, and change-of-control provisions relevant to Genpact’s debt structure.
On Stock Titan, AI-powered tools can help summarize lengthy filings, highlight key terms in 10-K and 10-Q reports, and surface notable items from Form 4 insider transaction reports where applicable. Real-time updates from EDGAR ensure that new Genpact filings appear promptly, allowing users to monitor financial performance, capital markets activity, and corporate governance developments through the company’s official regulatory disclosures.
Genpact Ltd: 03/13/2026 amendment shows The Vanguard Group reports 0 shares beneficially owned and 0% of Common Stock. The filing explains an internal realignment effective 01/12/2026 that led certain Vanguard subsidiaries to report ownership separately.
The statement lists no voting or dispositive power for Vanguard over Genpact common shares and affirms no single other person holds more than 5% of the class according to the report.
Genpact LTD Chief Financial Officer Michael Hal Weiner reported a tax-related share disposition linked to equity compensation. On the vesting of performance share units granted on March 15, 2023, 7,019 common shares were withheld at $38.92 per share to cover tax obligations. Following this non-market transaction, he holds 181,874 common shares directly.
Genpact Limited Senior Vice President Riju Vashisht reported a tax-related share disposition. On this Form 4, 7,080 common shares were withheld at $38.92 per share to cover taxes due upon vesting of performance share units granted on March 15, 2023. After this withholding, Vashisht directly holds 123,668 Genpact common shares.
Genpact LTD Senior Vice President Anil Nanduru reported a routine tax-withholding transaction related to equity compensation. On this Form 4, 7,663 common shares were withheld at a price of $38.92 per share to cover taxes due upon the vesting of performance share units granted on March 15, 2023 under Genpact’s 2017 Omnibus Incentive Compensation Plan. After this non-market disposition, Nanduru directly holds 105,539 common shares, indicating the filing reflects compensation-related tax settlement rather than an open-market sale.
Genpact Limited reported a routine compensation-related share withholding for its Senior Vice President and CHRO, Piyush Mehta. On March 10, 5,702 common shares were withheld at $38.92 per share to cover taxes upon vesting of performance share units granted on March 15, 2023. Following this tax-withholding disposition, Mehta directly holds 156,485 common shares, reflecting his ongoing equity stake in the company rather than an open-market sale.
Genpact Limited Senior Vice President Sameer Dewan reported a tax-related share disposition tied to equity compensation. On this Form 4, 3,542 common shares were withheld at a value of $38.92 per share to cover taxes upon vesting of performance share units granted on March 15, 2023.
After this withholding, Dewan directly holds 57,665 common shares. This transaction reflects routine tax withholding on vested performance-based awards under the Genpact Limited 2017 Omnibus Incentive Compensation Plan rather than an open-market purchase or sale decision.
Genpact Limited President and CEO Balkrishan Kalra reported a tax-related share withholding. On the vesting of performance share units granted on March 15, 2023, 13,893 common shares were withheld to cover tax obligations, rather than sold in the market. Following this non-market disposition, he continues to hold 511,114 common shares directly.
Genpact Limited is soliciting proxies for its 2026 Annual General Meeting on April 23, 2026 in New York. Shareholders are being asked to elect ten directors, approve executive pay on an advisory basis, and ratify KPMG as independent auditor for 2026.
For 2025, Genpact reported net revenues of $5.08 billion, up 6.6% year-over-year, with Advanced Technology Solutions reaching $1.20 billion, up 17.0% and now 24% of total revenue. Adjusted diluted EPS grew 11%, marking a fifth straight year of EPS growth outpacing revenue. The company highlights a strategy centered on AI- and agentic-based solutions, strong partner-driven revenue growth, and extensive governance practices including an independent chair, fully independent key committees, annual director elections, and robust shareholder engagement on compensation.
Genpact Ltd President and CEO Balkrishan Kalra reported multiple equity transactions. On March 4, 2026, he exercised an employee stock option for 2,800 common shares at $27.65 per share, then sold 2,800 common shares in an open‑market transaction at a weighted average price of $40.77, leaving 525,007 common shares held directly afterward.
On March 3, 2026, he also acquired 27,160 common shares as a grant or award at no cost, increasing his direct holdings. Footnotes note performance share units granted on March 15, 2023 that will vest on March 10, 2026, and 8,962 shares currently held under the employee stock purchase plan, including 587 shares bought since his prior Form 4.